TRAW: Traws Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 7.05
Enterprise Value ($M) -14.29
Book Value ($M) -31.63
Book Value / Share -6.23
Price / Book -0.22
NCAV ($M) -31.64
NCAV / Share -6.24
Price / NCAV -0.22

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -9.16
Return on Equity (ROE) -27.68

Liquidity (mrq)
Quick Ratio 2.16
Current Ratio 2.16

Balance Sheet (mrq) ($M)
Current Assets 24.95
Assets 24.96
Liabilities 56.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.23
Operating Income -24.91
Net Income -166.52
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -29.79
Cash from Investing -3.65
Cash from Financing 33.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
1 day ago 13G Adage Capital Management, L.P. 6.50
02-14 13G Ikarian Capital, LLC 9.99
02-14 13G Alyeska Investment Group, L.P. 9.90
02-13 13G Ayrton Capital LLC 9.90
01-29 13D/A Orbimed Advisors Llc 19.90 25.65
01-08 13G Perceptive Advisors Llc 9.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-12 23,888 41,589 57.44
2025-05-09 25,469 88,242 28.86
2025-05-08 100,637 229,651 43.82
2025-05-07 10,805 30,456 35.48

(click for more detail)

Similar Companies
TNFA – TNF Pharmaceuticals, Inc. TNXP – Tonix Pharmaceuticals Holding Corp.
TPST – Tempest Therapeutics, Inc. TSBX – Turnstone Biologics Corp.
TTNP – Titan Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io